Tumor Eradication by Wild-type p53-specific Cytotoxic T Lymphocytes

The tumor suppressor protein p53 is overexpressed in close to 50% of all human malignancies. The p53 protein is therefore an attractive target for immunotherapy. Cytotoxic T lymphocytes (CTLs) recognizing a murine wild-type p53 peptide, presented by the major histocompatibility complex class I molec...

Descripción completa

Detalles Bibliográficos
Autores principales: Vierboom, Michel P.M., Nijman, Hans W., Offringa, Rienk, van der Voort, Ellen I.H., van Hall, Thorbald, van den Broek, Lambert, Fleuren, Gert Jan, Kenemans, Peter, Kast, W. Martin, Melief, Cornelis J.M.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1997
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199025/
https://www.ncbi.nlm.nih.gov/pubmed/9271585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199025/
https://www.ncbi.nlm.nih.gov/pubmed/9271585

Ejemplares similares